Healthcare -
Biotechnology - NASDAQ - US
$ 6.295
-0.71 %
$ 430 M
Market Cap
-1.1
P/E
PHAT - OTHER LONG-TERM ASSETS
Other Long-term Assets PHAT - Phathom Pharmaceuticals, Inc.
12.8 M
LAST VALUE
512.41%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR